drugset / Trial / NCT06907849

124I-Evuzamitide PET/CT Imaging In Patients With Lumbar Spinal Stenosis and Carpal Tunnel Syndrome

NCT06907849 ↗

NaSingle-groupOpen-labelDiagnostic

Summary

This clinical trial will use the amyloid-binding radiotracer, 124I-evuzamitide, to potentially detect amyloid, in the heart and elsewhere, in patients who have a history of lumbar spinal stenosis and/or carpal tunnel syndrome.

Timeline

Start
2025-05
Primary completion
2027-03
Completion
2027-05

Drugs

EvaluationDrugModalityDoseRoute
Subject 124I-evuzamitide Peptide 1 mg Intravenous